World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
55980
World Ranking
13839
National Ranking
7024

Overview

Benjamin Djulbegovic is affiliated with the City Of Hope National Medical Center in the United States. Their research primarily focuses on medicine, with significant contributions in economics, econometrics, and finance. Within these broader areas, their subfield expertise includes economics and econometrics, public health, environmental and occupational health, general health professions, statistics, probability and uncertainty, and oncology.

The scientist's work addresses several key topics, including health systems, economic evaluations, and quality of life; meta-analysis and systematic reviews; clinical practice guidelines implementation; healthcare cost, quality, and practices; venous thromboembolism diagnosis and management; statistical methods in clinical trials; and advanced causal inference techniques.

Benjamin Djulbegovic has published in numerous academic venues, with the highest number of publications appearing in these journals:

  • Journal of Clinical Epidemiology (18 publications)
  • Journal of Evaluation in Clinical Practice (13 publications)
  • Blood Advances (11 publications)
  • Cancer Treatment and Research (9 publications)
  • Blood (6 publications)

Their recent papers include:

  • Older adult participation in cancer clinical trials: A systematic review of barriers and interventions (2020) in CA A Cancer Journal for Clinicians
  • GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making (2020) in Journal of Clinical Epidemiology
  • Defining Undertreatment and Overtreatment in Older Adults With Cancer: A Scoping Literature Review (2020) in Journal of Clinical Oncology
  • Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients With High-risk Cytogenetic Factors (2020) in JAMA Oncology
  • Discordant and inappropriate discordant recommendations in consensus and evidence based guidelines: empirical analysis (2021) in BMJ

Benjamin Djulbegovic has collaborated frequently with several coauthors, including:

  • Iztok Hozo, with 46 joint publications
  • Gordon Guyatt, with 23 joint publications
  • Liang Yao, with 7 joint publications
  • Elie A. Akl, with 6 joint publications
  • Adam Cuker, with 6 joint publications

In book publications, Djulbegovic has contributed to scientific literature through at least one book published by Springer Science+Business Media titled Threshold Decision-making in Clinical Medicine (2023).

Best Publications

  • Estimating the mean and variance from the median, range, and the size of a sample.

    Stela Pudar Hozo;Benjamin Djulbegovic;Iztok Hozo

  • GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)

    Gordon H. Guyatt;Andrew D. Oxman;Gunn Vist;Regina Kunz

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • Pharmaceutical industry sponsorship and research outcome and quality: systematic review

    Joel Lexchin;Lisa A Bero;Benjamin Djulbegovic;Otavio Clark

  • GRADE guidelines: 5. Rating the quality of evidence--publication bias

    Gordon H. Guyatt;Andrew D. Oxman;Victor Manuel Montori;Gunn Vist

  • How to increase value and reduce waste when research priorities are set

    Iain Chalmers;Michael B Bracken;Ben Djulbegovic;Silvio Garattini

  • GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength.

    Jeffrey C. Andrews;Holger J. Schünemann;Andrew D. Oxman;Kevin Pottie

  • Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*

    Jeffrey L. Carson;Brenda J. Grossman;Steven Kleinman;Alan T. Tinmouth

  • Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.

    J. Douglas Rizzo;Alan E. Lichtin;Steven H. Woolf;Jerome Seidenfeld

  • Recommendations on the Use of 18F-FDG PET in Oncology

    James W. Fletcher;James W. Fletcher;Benjamin Djulbegovic;Heloisa P. Soares;Barry A. Siegel

  • Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

    John Koreth;Richard Schlenk;Kenneth J. Kopecky;Sumihisa Honda

  • Platelet Transfusion: A Clinical Practice Guideline From the AABB

    Richard M. Kaufman;Benjamin Djulbegovic;Terry Gernsheimer;Steven Kleinman

  • Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.

    Charles L. Bennett;Samuel M. Silver;Benjamin Djulbegovic;Athena T. Samaras

  • Progress in evidence-based medicine: a quarter century on.

    Benjamin Djulbegovic;Benjamin Djulbegovic;Gordon H Guyatt

  • Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

    Richard I. Fisher;Steven H. Bernstein;Brad S. Kahl;Benjamin Djulbegovic

  • GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes.

    Gordon H. Guyatt;Andrew D. Oxman;Nancy Santesso;Mark Helfand

  • Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients

    Julia Bohlius;Jayne Wilson;Jerome Seidenfeld;Margaret Piper

  • Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.

    Julia Bohlius;Kurt Schmidlin;Corinne Brillant;Guido Schwarzer

  • The uncertainty principle and industry-sponsored research

    Benjamin Djulbegovic;Mensura Lacevic;Alan Cantor;Karen K Fields

  • Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.

    Brian G M Durie;Robert A. Kyle;Andrew Belch;William Bensinger

Frequent Co-Authors

Gordon H. Guyatt
Gordon H. Guyatt McMaster University
Gary H. Lyman
Gary H. Lyman Fred Hutchinson Cancer Research Center
Charles L. Bennett
Charles L. Bennett University of South Carolina
Holger J. Schünemann
Holger J. Schünemann Humanitas University
Mike Clarke
Mike Clarke Queen's University Belfast
Keith Wheatley
Keith Wheatley University of Birmingham
Elie A. Akl
Elie A. Akl American University of Beirut
Alan F. List
Alan F. List Precision BioSciences
Paul Glasziou
Paul Glasziou Bond University
Iain Chalmers
Iain Chalmers University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in launching or advancing a medical career, but not ready for the full commitment of a U.S. medical degree? There are many flexible and affordable online options to consider. For those looking to enter nursing quickly, lpn programs offer a fast-track route to start working as a licensed practical nurse.

If you’re passionate about mental health, psychiatric np programs allow nurses to specialize in psychiatric care and support patients with a range of mental health needs.

For those interested in leadership, a cheapest online healthcare administration degree helps students develop the management skills needed to oversee clinics, hospitals, or medical practices. Those seeking advanced roles can also explore the cheapest online mha programs, which further boost career prospects in healthcare management.

These pathways are ideal for students looking for flexibility, affordability, and quick entry into various healthcare roles, making them strong alternatives or complements to traditional medical education.

Best Scientists Citing Benjamin Djulbegovic

Trending Scientists